VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR)

CUSIP: 929033108

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,806,628
Total 13F shares
60,090,600
Share change
-855,873
Total reported value
$43,114,461
Price per share
$0.72
Number of holders
44
Value change
-$1,211,908
Number of buys
18
Number of sells
33

Quarterly Holders Quick Answers

What is CUSIP 929033108?
CUSIP 929033108 identifies VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VOR - VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
61%
39,646,039
$44,007,103 31 Dec 2024
13F
FMR LLC
13F
Company
9.9%
6,419,633
$7,125,792 31 Dec 2024
13F
5AM Venture Management, LLC
13F
Company
9.8%
6,361,723
$7,061,513 31 Dec 2024
13F
5AM Ventures VI, L.P.
3/4/5
10%+ Owner
class O/S missing
1,766,634
$3,215,274 16 Nov 2021
VANGUARD GROUP INC
13F
Company
3%
1,942,821
$2,156,531 31 Dec 2024
13F
JOHNSON & JOHNSON
13F
Company
1.7%
1,074,658
$1,192,870 31 Dec 2024
13F
Lynx1 Capital Management LP
13F
Company
0.98%
637,218
$707,312 31 Dec 2024
13F
Sarissa Capital Management LP
13F
Company
0.95%
618,000
$685,980 31 Dec 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.82%
529,500
$587,745 31 Dec 2024
13F
BlackRock, Inc.
13F
Company
0.75%
488,363
$542,083 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.65%
422,143
$468,712 31 Dec 2024
13F
Ensign Peak Advisors, Inc
13F
Company
0.51%
329,378
$365,610 31 Dec 2024
13F
Nathan D. Jorgensen
3/4/5
CHIEF FINANCIAL OFFICER
mixed-class rows
289,403
mixed-class rows
$331,455 06 May 2024
MAI Capital Management
13F
Company
0.44%
283,199
$314,351 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.4%
261,837
$290,639 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.31%
200,405
$222,450 31 Dec 2024
13F
EXCHANGE TRADED CONCEPTS, LLC
13F
Company
0.26%
165,805
$184,044 31 Dec 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.25%
163,064
$181,001 31 Dec 2024
13F
Eyal C. Attar
3/4/5
CHIEF MEDICAL OFFICER
mixed-class rows
441,625
mixed-class rows
$179,808 13 Feb 2025
MORGAN STANLEY
13F
Company
0.25%
159,910
$177,500 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.24%
157,617
$174,955 31 Dec 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.2%
132,600
$147,186 31 Dec 2024
13F
STATE STREET CORP
13F
Company
0.18%
115,934
$128,687 31 Dec 2024
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.18%
115,028
$127,681 31 Dec 2024
13F
Trustees of Columbia University in the City of New York
13F
Company
0.14%
91,910
$102,020 31 Dec 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.13%
86,685
$95,000 31 Dec 2024
13F
XTX Topco Ltd
13F
Company
0.11%
71,788
$79,685 31 Dec 2024
13F
Bollard Group LLC
13F
Company
0.09%
55,555
$62,000 31 Dec 2024
13F
Virtu Financial LLC
13F
Company
0.08%
54,470
$60,000 31 Dec 2024
13F
LMR Partners LLP
13F
Company
0.08%
51,111
$56,733 31 Dec 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.07%
44,728
$48,754 31 Dec 2024
13F
Amy Quinlan
3/4/5
Vice President of Finance
class O/S missing
50,312
$43,268 06 Nov 2024
MARSHALL WACE, LLP
13F
Company
0.06%
37,190
$41,281 31 Dec 2024
13F
GABELLI & Co INVESTMENT ADVISERS, INC.
13F
Company
0.05%
30,000
$33,300 31 Dec 2024
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.04%
28,090
$31,180 31 Dec 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.04%
27,500
$30,525 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.04%
26,698
$29,635 31 Dec 2024
13F
MONEY CONCEPTS CAPITAL CORP
13F
Company
0.04%
25,000
$27,750 31 Dec 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.02%
16,102
$17,873 31 Dec 2024
13F
UNITED BANK
13F
Company
0.02%
15,300
$16,983 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.02%
11,024
$12,237 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
10,667
$11,840 31 Dec 2024
13F
TWO SIGMA SECURITIES, LLC
13F
Company
0.02%
10,069
$11,177 31 Dec 2024
13F
WEDBUSH SECURITIES INC
13F
Company
0.02%
10,000
$11,000 31 Dec 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
4,569
$5,000 31 Dec 2024
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
3,601
$3,997 31 Dec 2024
13F
FEDERATED HERMES, INC.
13F
Company
0%
3,045
$3,380 31 Dec 2024
13F
GROUP ONE TRADING LLC
13F
Company
0%
2,422
$2,688 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
2,393
$2,656 31 Dec 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1,149
$1,275 31 Dec 2024
13F

Institutional Holders of VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) as of Q1 2025

As of 31 Mar 2025, VOR BIOPHARMA INC. - Common Stock, par value $0.0001 per share (VOR) was held by 44 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 60,090,600 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., FMR LLC, 5AM Venture Management, LLC, VANGUARD GROUP INC, JOHNSON & JOHNSON, RENAISSANCE TECHNOLOGIES LLC, Sarissa Capital Management LP, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 44 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
51
Q1 2025 holders
44
Holder diff
-7
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .